KENT, Ohio – April 2018 – PRESS RELEASE – Smithers-Oasis Company, a provider of solutions throughout the plant and flower supply chain from propagation to consumer, announces its partnership with Agrilyst, a provider of a software as a service (SaaS) product for greenhouses and vertical farms that allows growers to track crops, labor, inventory and other metrics.

Oasis Grower Solutions products will be included in Agrilyst, and offered to growers that subscribe to the software, which helps them manage their crops and provides data-driven insights to make more profitable production decisions. 

“With Agrilyst, we bring to the industry an understanding of how to leverage data, making it easier for growers to manage and scale their businesses,” said Allison Kopf, CEO of Agrilyst. “Including Oasis Grower Solutions products in our platform will enable indoor growers to know when and what to order so they can perform optimally.” 

The Agrilyst platform puts the power of precision agriculture in the hands of any grower, no matter what its size. The cloud-based platform leverages knowledge from other growers and offers a mobile app for ease of use. Indoor growers are able to extract data that helps them take control of their operations and improves their supply chain management.  

“Using Agrilyst, growers can spend their time and expertise focused on their flowers and vegetables, rather than trying to maintain their supply chain,” said Bill Riffey, general manager, grower operations, Americas, Europe and Africa. “As the industry moves more and more towards indoor growing because of climate changes, it is important for Smithers-Oasis to be involved in the latest technologies that innovative growers are using to help grow their businesses.” 

Oasis Grower Solutions horticulture products provide for the strong, healthy, clean start and post-harvest care and handling of plants and flowers throughout their lifecycle to ensure the best user experience. The entire plant journey includes the breeder, propagator, growers, retailers, distributors and finally, the end consumer. 

Top photo courtesy of Smithers-Oasis Company

JEFFERSON CITY • Patients with long-term illnesses could have access to smokeless forms of medical marijuana under a measure approved Tuesday in the Missouri House.

The bill’s sponsor, Rep. Jim Neely, R-Cameron, said the measure is intended to ease the pain of people who are about to die. But, it also covers patients suffering from debilitating conditions such as post-traumatic stress disorder and epilepsy.

RELATED: Missouri House Moves to Legalize Medical Marijuana

The measure was approved on a 112-44 vote. It now heads to the Senate for further debate. Neely said he was “optimistic” the proposal could make it through the Senate in the final three weeks of the legislative session.

“This is the right thing to do for Missouri,” said Neely, who is a physician.

Read more

Top Image: © selensergen | Adobe Stock

Members of the Senate's Aboriginal peoples committee are recommending the Liberal government hold back on legalizing cannabis for up to a year in order to address its potential for harmful effects in Indigenous communities.

The committee, chaired by Liberal Saskatchewan Sen. Lillian Dyck, said in its report on Bill C-45 that the government simply did not consult enough with First Nations, Inuit and Métis communities before pushing ahead with its plan to legalize the drug.

"Many communities are really worried about the potential adverse effects on their members, and especially on their youth, and it may be even worse because of the trauma in their communities," Dyck said, adding existing social issues in Indigenous communities could be made worse by increased drug use.

If passed, the amendment would delay the bill's full implementation for up to a year.

Read more

BERKELEY, Calif., April 30, 2018 /PRNewswire/ -- PRESS RELEASE -- Jmîchaele Keller, CEO and chairman of the board of Steep Hill, Inc., a cannabis science, genetics, research, testing and analytics company, has announced that Steep Hill will expand into Mexico and six new European Union markets, offering full service cannabis quality assurance to the strategic Mexican and European markets as they open and legalize cannabis for the benefit of their patients. "It is an exciting time for us and our investors, as we pursue this first-mover advantage in anticipation of new global cannabis import-export markets," said Keller.

The licensee for Steep Hill Canada will expand their testing umbrella to include Steep Hill Mexico, Steep Hill Germany, Steep Hill Spain, Steep Hill France, Steep Hill Italy, Steep Hill Switzerland and Steep Hill United Kingdom. Martin Shefsky, CEO, Steep Hill Worldwide, said, "I'm extremely pleased at the opportunity to partner with Steep Hill to bring safe cannabis and scientific integrity to emerging international markets. I anticipate that before long, full legalization will be implemented throughout the European Union and our presence will enable growers, producers, processors and retailers to offer standardized tested cannabis for patients and consumers across the European Union, while also enabling us to create a platform to share scientific and technology developments throughout the global cannabis market.  We are actively seeking operating partners with local market experience to join us in several of our strategic territories."

In making the announcement, Keller said, "Steep Hill's continued global expansion is blazing the trail, defining the future of cannabis testing which will strategically position us prior to full legalization in the European Union and ensure these markets will offer superior quality standardization of cannabis testing and safe medicine for all patients on Day One."  

Keller continued, "In unregulated markets, we want to be on the ground supporting the legalization and regulatory process, helping regulators avoid making the mistakes that other jurisdictions have made in the past. We believe that our role as the industry standard, allows us to leverage our world-class scientific knowledge and state of the art technology to help regulators provide confidence in the marketplace that the cannabis patients consume, is both safe and effective. We look forward to collaborating closely with Martin and his group to strive for this gold standard, across all international borders."

For more information on Steep Hill's licensee program, visit: https://landing.steephill.com/licensing/